Your browser doesn't support javascript.
loading
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.
Reinhardt, Bryanna; Habib, Omar; Shaw, Kit L; Garabedian, Elizabeth; Carbonaro-Sarracino, Denise A; Terrazas, Dayna; Fernandez, Beatriz Campo; De Oliveira, Satiro; Moore, Theodore B; Ikeda, Alan K; Engel, Barbara C; Podsakoff, Gregory M; Hollis, Roger P; Fernandes, Augustine; Jackson, Connie; Shupien, Sally; Mishra, Suparna; Davila, Alejandra; Mottahedeh, Jack; Vitomirov, Andrej; Meng, Wenzhao; Rosenfeld, Aaron M; Roche, Aoife M; Hokama, Pascha; Reddy, Shantan; Everett, John; Wang, Xiaoyan; Luning Prak, Eline T; Cornetta, Kenneth; Hershfield, Michael S; Sokolic, Robert; De Ravin, Suk See; Malech, Harry L; Bushman, Frederic D; Candotti, Fabio; Kohn, Donald B.
Afiliação
  • Reinhardt B; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Habib O; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Shaw KL; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Garabedian E; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
  • Carbonaro-Sarracino DA; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Terrazas D; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Fernandez BC; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • De Oliveira S; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA.
  • Moore TB; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA.
  • Ikeda AK; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA.
  • Engel BC; Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Podsakoff GM; Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Hollis RP; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Fernandes A; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Jackson C; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Shupien S; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA.
  • Mishra S; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Davila A; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Mottahedeh J; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Vitomirov A; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Meng W; Department of Pathology and Laboratory Medicine and.
  • Rosenfeld AM; Department of Pathology and Laboratory Medicine and.
  • Roche AM; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Hokama P; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Reddy S; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Everett J; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Wang X; Department of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
  • Luning Prak ET; Department of Pathology and Laboratory Medicine and.
  • Cornetta K; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.
  • Hershfield MS; Departments of Medicine and Biochemistry, Duke University School of Medicine, Durham, NC.
  • Sokolic R; Department of Medicine, Alpert Medical School, Brown University, Providence, RI.
  • De Ravin SS; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.
  • Malech HL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.
  • Bushman FD; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Candotti F; Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Kohn DB; Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
Blood ; 138(15): 1304-1316, 2021 10 14.
Article em En | MEDLINE | ID: mdl-33974038

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Imunodeficiência Combinada Severa / Agamaglobulinemia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Imunodeficiência Combinada Severa / Agamaglobulinemia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá